Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Neuroradiology ; 46(7): 541-9, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15105980

ABSTRACT

Recurrent contrast-enhancing lesions arising within foci of prior brain neoplasms treated with chemotherapy and/or radiation therapy pose a significant diagnostic dilemma, as they may represent recurrent or residual tumor, treatment-related changes, or a combination of both. Those lesions specifically in the posterior fossa are even more difficult to assess, given the technical limitations of 2D CSI in the infratentorial compartment. We explored the feasibility of 2D-CSI MR spectroscopy in the evaluation of recurrent contrast-enhancing lesions in eight consecutive patients who had undergone treatment for posterior fossa or brainstem tumors. Mean Cho/Cr (choline/creatine) ratios obtained by 2D-CSI in recurrent tumor, treatment-related changes, and normal white matter were 2.93, 1.62, and 0.97, respectively, mean Cho/NAA (choline/N-Acetyl aspartate) ratios were 4.34, 1.74, and 0.93, and mean NAA/Cr (N-acetyl aspartate/creatine) ratios were 0.74, 0.92, and 1.26, respectively. In conclusion, also in the posterior fossa, MR spectroscopy is likely to be useful as an adjunct to conventional imaging characteristics in distinguishing recurrent tumor from treatment-related changes, irrespectively of the MRS technique used. In most cases spectra of diagnostic quality can be obtained using 2D-CSI to include coverage of both the lesion and its vicinity.


Subject(s)
Brain Neoplasms/diagnosis , Brain Stem Neoplasms/diagnosis , Infratentorial Neoplasms/diagnosis , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Neoplasm Recurrence, Local/diagnosis , Adult , Brain Neoplasms/therapy , Brain Stem Neoplasms/therapy , Feasibility Studies , Female , Humans , Infratentorial Neoplasms/therapy , Male
2.
Magn Reson Med ; 41(2): 257-67, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10080272

ABSTRACT

Prognostication in patients with liposarcoma is a complex and controversial subject based on recognition of lipoblasts, adipocyte nuclear atypia, and qualitative estimations of cellularity and cell size. We show here that for 30 patients with liposarcoma and 5 patients with lipoma, spectral differences on high-resolution, magic angle spinning proton nuclear magnetic resonance (hr-MAS 1H-NMR) spectroscopy relate to known biochemical changes and correlate with adipocyte tissue differentiation, histologic cell type, and cellularity. The NMR-visible level of triglyceride is shown to correlate with liposarcoma differentiation, since the triglyceride level in well-differentiated liposarcoma is 33-fold higher on average than for myxoid/round cell liposarcoma, which in turn is 6-fold higher than the dedifferentiated and/or pleomorphic subtypes. The NMR-visible phosphatidylcholine level serves as an estimate of total tissue cell membrane phospholipid mass and was found to correlate with liposarcoma subtype. Pleomorphic liposarcoma, the most aggressive and metastatic subtype, was found to have a threefold increase in NMR-visible phosphatidylcholine level compared with dedifferentiated liposarcoma. The level of NMR-visible phosphatidylcholine was twofold greater in well-differentiated liposarcoma compared with lipoma and was threefold larger for the hypercellular myxoid/round cell subtype compared with the pure myxoid histology. Thus, NMR-derived parameters of tissue lipid may be used for objective distinction of liposarcoma histologic subtype/grade and lipoma from liposarcoma. These biochemical parameters may ultimately improve prognostication in patients with liposarcoma.


Subject(s)
Lipoma/classification , Liposarcoma/classification , Magnetic Resonance Spectroscopy , Humans , Lipoma/chemistry , Lipoma/pathology , Liposarcoma/chemistry , Liposarcoma/pathology , Prognosis
3.
Magn Reson Med ; 39(3): 337-45, 1998 Mar.
Article in English | MEDLINE | ID: mdl-9498588

ABSTRACT

The application of new gradient, high-resolution, magic angle spinning (MAS) 1H nuclear magnetic resonance (NMR) spectroscopy to the study of intact undifferentiated and differentiated NIH 3T3 F442A cells demonstrated improved spectral resolution and sensitivity compared with static studies. MAS of cells permits the detection and quantitation of many cellular metabolites that are not clearly resolved in nonspinning measurements and provides an improved visibility of phospholipids. Gradient, MAS enables the use of diffusion weighting for compartment assignment and the determination of mobility for many metabolites which are incompletely resolved using static techniques. The smaller, undifferentiated preadipocytes show no microscopic evidence of cell lysis after 2 h of MAS at 3.5 kHz and 82% of these cells remain viable by trypan blue exclusion. In contrast, 15-19% of the larger, lipid-laden differentiated adipocytes were found to suffer some degree of cell lysis with MAS. This new method is an attractive alternative to either nonspinning perfusion or extraction techniques for NMR studies of cells.


Subject(s)
Adipocytes/metabolism , Magnetic Resonance Spectroscopy/methods , 3T3 Cells , Adipocytes/cytology , Animals , Cell Count , Cell Differentiation , Cell Line , Cell Membrane/ultrastructure , Cell Survival , Choline/analysis , Coloring Agents , Diffusion , Hydrocarbons , Hydrogen , Inositol/analysis , Lipid Metabolism , Lipids/analysis , Membrane Lipids/analysis , Methane/analogs & derivatives , Methane/analysis , Mice , Phosphatidylcholines/analysis , Phospholipids/analysis , Phospholipids/metabolism , Phosphorylcholine/analysis , Triglycerides/analysis , Trypan Blue
SELECTION OF CITATIONS
SEARCH DETAIL
...